• 

  Phil’s Journal: Using AI to Work Around My Alzheimer’s Cognitive Decline
• 

  Phil’s Journal: Cancer Vs. Alzheimer’s
• 

  Phil’s Journal: C2N’s Alzheimer’s Blood Test
• 

  Phil’s Journal: On ‘Entering the Era of Alzheimer’s Treatment’
• 

  Phil’s Journal: Will New Alzheimer’s Drugs Work for As Well for Women as They Do for Men?
• 

  Phil’s Journal: Dispatch from AAIC, Day One
• 

  Phil’s Journal: Before AAIC In Amsterdam, Leading Alzheimer’s Advocates Weigh In
• 

  Phil’s Journal: What Is ‘Quality of Life?’ A Sad Farewell and a Tough Deciscion
• 

  Phil’s Journal: Legos, Lewy Body Symptoms, and, Maybe, the End of Aduhelm Access
• 

  Phil’s Journal: After 17 Marathons, Taking Up the Torch Again for Brain Health
• 

  Phil’s Journal: Better Cognitive Assessments Are On the Way—I Tried One
• 

  Phil’s Journal: Another Alzheimer’s Drug, Lecanemab, Wins Early Approval—So, What Now?
• 

  Phil’s Journal: Meet New Alzheimer’s Association CEO Joanne Pike
• 

  Phil’s Journal: A Note on Gratitude and Giving
• 

  Phil’s Journal: Dog Dementia, or Bea’s Story

12Next